Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HEPARIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 467 adverse event reports in the FDA FAERS database where HEPARIN was used for Atrial fibrillation.

Most Reported Side Effects for HEPARIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,294 12.6% 346 1,024
Heparin-induced thrombocytopenia 2,057 11.3% 366 1,127
Off label use 1,077 5.9% 334 542
Thrombocytopenia 781 4.3% 106 418
Haemorrhage 684 3.8% 157 328
Pulmonary embolism 652 3.6% 254 440
Drug hypersensitivity 629 3.5% 117 179
Thrombosis 603 3.3% 200 299
Foetal exposure during pregnancy 582 3.2% 58 107
Anaemia 576 3.2% 188 431
Maternal exposure during pregnancy 561 3.1% 16 170
Condition aggravated 552 3.0% 252 365
Multiple organ dysfunction syndrome 476 2.6% 441 239
Gastrointestinal haemorrhage 454 2.5% 127 291
Premature baby 452 2.5% 40 84

Other Indications for HEPARIN

Product used for unknown indication (3,746) Anticoagulant therapy (3,476) Thrombosis prophylaxis (1,633) Pulmonary embolism (786) Deep vein thrombosis (603) Prophylaxis (464) Thrombosis (378) Acute myocardial infarction (294) Foetal exposure during pregnancy (179) Catheterisation cardiac (153)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

HEPARIN Full Profile All Atrial fibrillation Drugs HEPARIN Demographics HEPARIN Timeline